15 June 2020

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

15 June 2020 | n=38

  1. Bouzidi KEL, Jose S, Phillips AN, Pozniak A, et al.
    First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines: a cohort study.
    AIDS 2020.

  2. Petrakis V, Panagopoulos P, Papachristou S, Papanas N, et al.
    Tenofovir alafenamide fumarate therapy for HIV treatment: Cardiometabolic and renal safety.
    AIDS Res Hum Retroviruses 2020.

  3. Dabee S, Mkhize NN, Jaspan HB, Lewis D, et al.
    Initiation of antiretroviral therapy differentially influences genital and systemic immune activation in HIV-infected women.
    AIDS Res Hum Retroviruses 2020.

  4. Karris M, Berko J, Mazonson P, Loo T, et al.
    Association of Pain and Pain Medication Use with Multiple Characteristics of Older People Living with HIV.
    AIDS Res Hum Retroviruses 2020.

  5. Murray DD, Zaunders J, Milliken ST, Munier CML, et al.
    Altered immune reconstitution in HIV positive allogeneic stem cell transplant recipients.
    Clin Infect Dis 2020.

  6. Peebles K, Kiweewa FM, Palanee-Phillips T, Chappell C, et al.
    Elevated Risk of Bacterial Vaginosis among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study.
    Clin Infect Dis 2020.

  7. Kronfli N, Young J, Wang S, Cox J, et al.
    Liver fibrosis in HIV-Hepatitis C virus (HCV) co-infection before and after sustained virologic response: what is the best non-invasive marker for monitoring regression?
    Clin Infect Dis 2020.

  8. Massanella M, Puthanakit T, Leyre L, Jupimai T, et al.
    Continuous prophylactic ARV/ART since birth reduces seeding and persistence of the viral reservoir in vertically HIV-infected children.
    Clin Infect Dis 2020.

  9. .
    Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials: Erratum.
    J Acquir Immune Defic Syndr 2020;84:e21.

  10. Ramirez-Marrero FA, Perez-Frontera S, Amalbert-Birriel MA, Matos M, et al.
    Brief Report: Effects of Low-Volume High-Intensity Interval Training in Hispanic HIV+ Women: A Nonrandomized Study.
    J Acquir Immune Defic Syndr 2020;84:285-289.

  11. Philbin MM, Parish CL, Kinnard EN, Reed SE, et al.
    Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy.
    J Acquir Immune Defic Syndr 2020;84:263-270.

  12. Kalichman SC, Eaton LA, Berman M, Kalichman MO, et al.
    Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living with HIV, Atlanta, Georgia.
    J Acquir Immune Defic Syndr 2020.

  13. Macneal K, Tukei V, Sacks E, Mokone M, et al.
    Use of Point-of-Care Nucleic Acid Tests Beyond Early Infant Diagnosis of HIV: A Retrospective Case Review in Lesotho.
    J Acquir Immune Defic Syndr 2020;84 S:S78-S83.

  14. Adetunji O, Mukherjee S, Sacks E, Ciaranello A, et al.
    Front-Line Human Resource Time-Use for Early Infant HIV Diagnosis: A Comparative Time-Motion Study at Centralized and Point-of-Care Health Facilities in Zimbabwe.
    J Acquir Immune Defic Syndr 2020;84 S:S70-S77.

  15. Mukherjee S, Cohn J, Ciaranello AL, Sacks E, et al.
    Estimating the Cost of Point-of-Care Early Infant Diagnosis in a Program Setting: A Case Study Using Abbott m-PIMA and Cepheid GeneXpert IV in Zimbabwe.
    J Acquir Immune Defic Syndr 2020;84 S:S63-S69.

  16. Alemnji G, Peter T, Vojnov L, Alexander H, et al.
    Building and Sustaining Optimized Diagnostic Networks to Scale-up HIV Viral Load and Early Infant Diagnosis.
    J Acquir Immune Defic Syndr 2020;84 S:S56-S62.

  17. Katirayi L, Ochuka B, Mafaune H, Chadambuka A, et al.
    "We Need it the Same Day": A Qualitative Study of Caregivers and Community Members' Perspectives Toward the Use of Point-of-Care Early Infant Diagnosis.
    J Acquir Immune Defic Syndr 2020;84 S:S49-S55.

  18. Bianchi F, Clemens S, Arif Z, Sacks E, et al.
    Acceptability of Routine Point-of-Care Early Infant Diagnosis in Eight African Countries: Findings From a Qualitative Assessment of Clinical and Laboratory Personnel.
    J Acquir Immune Defic Syndr 2020;84 S:S41-S48.

  19. Tchendjou P, Nzima V, Lekeumo S, Sacks E, et al.
    HIV Mother-to-Child Transmission in Cameroon: EID Positivity Yields and Key Risk Factors by Health Service Points After Usage of POC EID Systems.
    J Acquir Immune Defic Syndr 2020;84 S:S34-S40.

  20. Mafaune HW, Sacks E, Chadambuka A, Musarandega R, et al.
    Effectiveness of Maternal Transmission Risk Stratification in Identification of Infants for HIV Birth Testing: Lessons From Zimbabwe.
    J Acquir Immune Defic Syndr 2020;84 S:S28-S33.

  21. Khumalo PN, Sacks E, Chouraya C, Tsabedze B, et al.
    The Cascade of Care From Routine Point-of-Care HIV Testing at Birth: Results From an 18-Months Pilot Program in Eswatini.
    J Acquir Immune Defic Syndr 2020;84 S:S22-S27.

  22. McCann NC, Cohn J, Flanagan C, Sacks E, et al.
    Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.
    J Acquir Immune Defic Syndr 2020;84 S:S12-S21.

  23. Sacks E, Cohn J, Ochuka B, Mafaune H, et al.
    Impact of Routine Point-of-Care Versus Laboratory Testing for Early Infant Diagnosis of HIV: Results From a Multicountry Stepped-Wedge Cluster-Randomized Controlled Trial.
    J Acquir Immune Defic Syndr 2020;84 S:S5-S11.

  24. Mofenson LM, Cohn J, Sacks E.
    Challenges in the Early Infant HIV Diagnosis and Treatment Cascade.
    J Acquir Immune Defic Syndr 2020;84 S:S1-S4.

  25. Etoori D, Gomez-Olive FX, Reniers G, Rice B, et al.
    Outcomes after being lost to follow-up differ for pregnant and postpartum women when compared to the general HIV treatment population in rural South Africa.
    J Acquir Immune Defic Syndr 2020.

  26. Gomez-Olive FX, Houle B, Rosenberg M, Kabudula C, et al.
    HIV incidence among older adults in a rural South African setting: 2010-2015.
    J Acquir Immune Defic Syndr 2020.

  27. Kingery JR, Goyal P, Hosalli R, Lee MH, et al.
    HIV-Associated Myocardial Diastolic Dysfunction and Soluble ST2 Concentration in Tanzanian Adults: A Cross-Sectional Study.
    J Infect Dis 2020.

  28. Dawson L, Benbow N, Fletcher FE, Kassaye S, et al.
    Addressing ethical challenges in US-based HIV phylogenetic research.
    J Infect Dis 2020.

  29. Laplana M, Bravo MJ, Fernandez-Fuertes M, Ruiz-Garcia C, et al.
    Toll Like Receptor 2 promoter -196 to -174 deletion affects CD4 levels along HIV infection progression.
    J Infect Dis 2020.

  30. Li W, Ma Q, Wang X, Tang M, et al.
    Letter to the Editor: The characteristics of two patients co-infected with SARS-CoV-2 and HIV in Wuhan, China.
    J Med Virol 2020.

  31. Sebastiao CS, Neto Z, Jandondo D, Mirandela M, et al.
    HIV, hepatitis B virus, hepatitis C virus, and syphilis among pregnant women attending antenatal care in Luanda, Angola: seroprevalence and risk factors.
    J Med Virol 2020.

  32. Lu M, Ma X, Reichard N, Terry DS, et al.
    Shedding-resistant HIV-1 envelope glycoproteins adopt downstream conformations that remain responsive to conformation-preferring ligands.
    J Virol 2020.

  33. Thamamongood T, Aebischer A, Wagner V, Chang MW, et al.
    A genome-wide CRISPR-Cas9 screen reveals the requirement of host cell sulfation for Schmallenberg virus infection.
    J Virol 2020.

  34. Nimmo C, Naidoo K, O'Donnell M.
    Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
    N Engl J Med 2020;382:2376.

  35. Schaaf HS, Garcia-Prats AJ, Draper HR, Rautenbach C, et al.
    Trends in Drug Resistance in Childhood Tuberculosis in Cape Town, South Africa.
    Pediatr Infect Dis J 2020;39:604-608.

  36. Ejigu Y, Magnus JH, Sundby J, Magnus MC, et al.
    Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure.
    Pediatr Infect Dis J 2020.

  37. Vasavda C, Ho BK, Snyder SH.
    Ease restrictions on U.S. blood donations.
    Science 2020;368:957.

  38. Cohen J.
    Long-acting drug acts like a short-term AIDS vaccine.
    Science 2020;368:807.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

13 July 2020

06 July 2020

29 June 2020

22 June 2020

15 June 2020

15 June 2020

Multidisciplinary Journal Club

  1. Hughes D, Judge C, Murphy R, Loughlin E, et al.
    Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis.
    JAMA. 2020;323:1934-1944.

  2. Kimball A, Torrone E, Miele K, Bachmann L, et al.
    Missed Opportunities for Prevention of Congenital Syphilis - United States, 2018.
    MMWR Morb Mortal Wkly Rep. 2020;69:661-665.

  3. Lee H, Yano Y, Cho SMJ, Park JH, et al.
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016